Altitude Life Science Ventures (ALSV)
Venture Capital
Active
Durango, United States
43
90M
25
2.39
0.40
9
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Durango. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Altitude Life Science Ventures, startups are often financed by Venrock, OUP (Osage University Partners), Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Venrock, The Column Group, Versant Ventures. In the next rounds fund is usually obtained by The Column Group, Venrock, Third Rock Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Life Science, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Receptos, Vir Biotechnology, Kythera Biopharmaceuticals. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
The current fund was established by Dave Maki, David Maki, Steve Johnson, Steve Johnson. The overall number of key employees were 2.
The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this Altitude Life Science Ventures performs on 7 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 50 - 100 millions dollars. The top activity for fund was in 2019. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 43
- Lead investments
- 0
- Exits
- 9
- Rounds per year
- 2.39
- Follow on index
- 0.40
- Investments by industry
- Biotechnology (40)
- Health Care (16)
- Therapeutics (13)
- Medical (12)
- Biopharma (9) Show 12 more
- Investments by region
-
- United States (40)
- Peak activity year
- 2021
- Number of Unicorns
- 3
- Number of Decacorns
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 208M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 3.49
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Encoded Therapeutics | 26 Jun 2019 | Biotechnology, Health Care, Genetics, Therapeutics | Late Stage Venture | 104M | United States, California, South San Francisco |
Vilya | 04 Jun 2024 | Biotechnology, Health Diagnostics, Medical, Life Science | Early Stage Venture | 21M | United States, Washington, Seattle |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.